Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
Qi Tang, Francesco Buonfiglio, Elsa Wilma Böhm, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 594-594
Open Access | Times Cited: 12

Showing 12 citing articles:

Mechanisms Underlying Vascular Inflammaging: Current Insights and Potential Treatment Approaches
Ying Zeng, Francesco Buonfiglio, Jingyan Li, et al.
Aging and Disease (2025)
Open Access
Exploring Endothelial Cell Dysfunction’s Impact on the Brain-Retina Microenvironment Connection: Molecular Mechanisms and Implications
Wahid Shah, Yuanyuan Gong, Xinhan Qiao, et al.
Molecular Neurobiology (2025)
Closed Access
Letter to the Editor: Potential of Activated Growth Factor From Platelets in Diabetic Retinopathy Treatment [Letter]
Sari Luthfiyah, Triwiyanto Triwiyanto, Mohammed Ismath
Diabetes Metabolic Syndrome and Obesity (2025) Vol. Volume 18, pp. 465-466
Open Access
Short-Term Clinical Outcomes of Patients with Diabetic Macular Edema Following a Therapy Switch to Faricimab
Peter Wolfrum, Elsa Wilma Böhm, Katrin Lorenz, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4508-4508
Open Access | Times Cited: 2
Oxidative Stress in Cataract Formation: Is There a Treatment Approach on the Horizon?
Jingyan Li, Francesco Buonfiglio, Ying Zeng, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1249-1249
Open Access | Times Cited: 1
Mechanism and Therapeutic Targets of Circulating Immune Cells in Diabetic Retinopathy
Bowen Zhao, Yin Zhao, Xufang Sun
Pharmacological Research (2024) Vol. 210, pp. 107505-107505
Open Access | Times Cited: 1
Advanced drug delivery strategies for diabetic retinopathy: a comprehensive review on current medications, delivery methods, device innovations, overcoming barriers, and experimental models
Mengistie Diress, Susbin Raj Wagle, Patrick J. Lim, et al.
Expert Opinion on Drug Delivery (2024)
Closed Access | Times Cited: 1
Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics
Anthony J. Evans, Yu‐Long Li
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12464-12464
Open Access | Times Cited: 1
Ocular immune‐related diseases: molecular mechanisms and therapy
Yakun Wang, Shangze Gao, Fan Cao, et al.
MedComm (2024) Vol. 5, Iss. 12
Closed Access | Times Cited: 1
Cancer to Cataracts: The Mechanistic Impact of Aldo-Keto Reductases in Chronic Diseases
Anirudh P. Shanbhag, Purnendu Bhowmik
The Yale Journal of Biology and Medicine (2024) Vol. 97, Iss. 2, pp. 179-204
Open Access
Paquinimod attenuates retinal injuries by suppressing the S100A9/TLR4 signaling in an experimental model of diabetic retinopathy
Can Deng, Xiaomeng Li, Min Ren, et al.
Experimental Eye Research (2024), pp. 110131-110131
Closed Access
Mitochondrial DNA variants in the pathogenesis and metabolic alterations of diabetes mellitus
Praveen Kumar K. S., M. N. Jyothi, Akila Prashant
Molecular Genetics and Metabolism Reports (2024) Vol. 42, pp. 101183-101183
Closed Access
Page 1

Scroll to top